Art. 4 Directive (EU) 2001/83

In forcesince 30 Dec 2008cited 28×
1.

Nothing in this Directive shall in any way derogate from the Community rules for the radiation protection of persons undergoing medical examination or treatment, or from the Community rules laying down the basic safety standards for the health protection of the general public and workers against the dangers of ionizing radiation.

2.

This Directive shall be without prejudice to Council Decision 86/346/EEC of 25 June 1986 accepting on behalf of the Community the European Agreement on the Exchange of Therapeutic Substances of Human Origin [OJ L 207, 30.7.1986, p. 1.].

3.

The provisions of this Directive shall not affect the powers of the Member States' authorities either as regards the setting of prices for medicinal products or their inclusion in the scope of national health insurance schemes, on the basis of health, economic and social conditions.

4.

This Directive shall not affect the application of national legislation prohibiting or restricting the sale, supply or use of medicinal products as contraceptives or abortifacients. The Member States shall communicate the national legislation concerned to the Commission.

5.

This Directive and all Regulations referred to therein shall not affect the application of national legislation prohibiting or restricting the use of any specific type of human or animal cells, or the sale, supply or use of medicinal products containing, consisting of or derived from these cells, on grounds not dealt with in the aforementioned Community legislation. The Member States shall communicate the national legislation concerned to the Commission. The Commission shall make this information publicly available in a register.

The 10 that are cited most themselves, of 28.

  • Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…13Law

    1. Без да се засягат разпоредбите на член 4, параграфи 4 и 5 от Директива 2001/83/ЕО, разрешението за пускане на пазара, предоставено …

  • GmS-OGB, Beschluss vom 22. August 2012 - GmS-OGB 1/10Decision

    a) Nach Art. 4 Abs. 3 der Richtlinie 2001/83/EG vom 6. November 2001 zur Schaffung eines Gemeinschaftskodexes für Humanarzneimittel (ABl. L 311 vom 28. November 2001, S. 67) berühren ihre Bestimmungen nicht die Zuständigkeit der …

    22 Aug 2012 · KORE300212013

  • Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 Novembe…27Law

    … се заменя със следното: „Без да се засягат разпоредбите на член 4, параграфи 4 и 5 от Директива 2001/83/ЕО, разрешението за пускане на …

  • Judgment of the Court (Fourth Chamber), 10 July 2014. Markus D. and G.Decision

    That conclusion is not affected by the argument that, in essence, that interpretation is at odds with the intention of the legislature, which designated as medicinal products in Article 4(4) of Directive 2001/83 ‘contraceptives or …

    10 Jul 2014 · 62013CJ0358

  • Judgment of the Court (Third Chamber), 29 March 2012. European Commission v Republic of Poland.Decision

    Finally, the Member States remain competent to set the price of medicinal products and the level of reimbursement by the national heath insurance scheme, on the basis of health, economic and social conditions, as is apparent from Article …

    29 Mar 2012 · 62010CJ0185

  • Judgment of the Court (Fourth Chamber) of 22 April 2010. The Queen, on the application of Association of the British Pharmaceutical IndustryDecision

    Article 4(3) of the directive states: ‘The provisions of this Directive shall not affect the powers of the Member States’ authorities either as regards the setting of prices for medicinal products or their inclusion in the scope of …

    22 Apr 2010 · 62009CJ0062

  • BGH, Urteil vom 6. Juni 2019 - I ZR 206/17Decision

    Brötchen-Gutschein 1. Gemäß Art. 4 Abs. 3 der Richtlinie 2001/83/EG zur Schaffung eines Gemeinschaftskodexes für Humanarzneimittel bleiben nationale Vorschriften zur Preisbindung und zu ihrer Einhaltung von dieser Richtlinie …

    6 Jun 2019 · KORE305152019

  • BGH, Urteil vom 6. Juni 2019 - I ZR 60/18Decision

    … Nach Art. 4 Abs. 3 der Richtlinie 2001/83/EG berühren die Bestimmungen dieser Richtlinie nicht die Zuständigkeiten der Behörden der Mitgliedstaaten hinsichtlich der Festsetzung der Arzneimittelpreise und ihrer Einbeziehung in den …

    6 Jun 2019 · KORE628502019

  • BGH, Vorlagebeschluss vom 9. September 2010 - I ZR 72/08Decision

    … Eine Aussage zur Preisfestsetzungskompetenz der Mitgliedstaaten enthält erst Art. 4 Abs. 3 der Richtlinie 2001/83/EG. Diese Vorschrift bestimmt jedoch ausdrücklich, dass die Zuständigkeiten der Behörden der Mitgliedstaaten hinsichtlich …

    9 Sep 2010 · KORE315972010

  • Opinion of Advocate General Sharpston delivered on 31 January 2013. Novartis Pharma GmbH v Apozyt GmbH.Decision

    Artikel 13, stk. 1, er affattet således: »Med forbehold af artikel 4, stk. 4 og 5, i direktiv 2001/83/EF gælder en markedsføringstilladelse, der er udstedt efter denne forordning, i hele Fællesskabet. En sådan …

    31 Jan 2013 · 62011CC0535